XTX Topco’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
25,017
+5,463
| +28% | +$687K | 0.13% | 177 |
|
|
2025
Q1 | $2.16M | Buy |
19,554
+12,688
| +185% | +$1.4M | 0.11% | 233 |
|
|
2024
Q4 | $937K | Sell |
6,866
-1,799
| -21% | -$246K | 0.08% | 334 |
|
|
2024
Q3 | $998K | Buy |
8,665
+5,322
| +159% | +$613K | 0.07% | 427 |
|
|
2024
Q2 | $460K | Sell |
3,343
-4,464
| -57% | -$615K | 0.04% | 698 |
|
|
2024
Q1 | $1.08M | Buy |
7,807
+3,342
| +75% | +$461K | 0.15% | 139 |
|
|
2023
Q4 | $588K | Buy |
4,465
+1,200
| +37% | +$158K | 0.13% | 179 |
|
|
2023
Q3 | $367K | Sell |
3,265
-5,243
| -62% | -$590K | 0.06% | 593 |
|
|
2023
Q2 | $802K | Buy |
8,508
+4,080
| +92% | +$385K | 0.14% | 153 |
|
|
2023
Q1 | $448K | Buy |
4,428
+19
| +0.4% | +$1.92K | 0.09% | 363 |
|
|
2022
Q4 | $527K | Buy |
4,409
+1,402
| +47% | +$167K | 0.11% | 276 |
|
|
2022
Q3 | $319K | Sell |
3,007
-507
| -14% | -$53.8K | 0.08% | 464 |
|
|
2022
Q2 | $343K | Buy |
+3,514
| New | +$343K | 0.14% | 228 |
|